Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7512)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2023 (publication date) through Nov 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2023; 14(3): 188-197 [PMID: 37035222 DOI: 10.4239/wjd.v14.i3.188] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2023; 14(3): 188-197 [PMID: 37035222 DOI: 10.4239/wjd.v14.i3.188] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i3/188.htm |
| Number | Citing Articles |
| 1 |
Wanwarang Wongcharoen, Rungroj Krittayaphong, Wacin Buddhari, Songsak Kiatchoosakun, Apiradee Sriwijitkamol, Taweesak Wannachalee, Arintaya Phrommintikul. Expert Opinion on the Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Established or High‑risk Atherosclerotic Cardiovascular Disease in Thailand. Journal of Asian Pacific Society of Cardiology 2025; 4 doi: 10.15420/japsc.2024.14
|
| 2 |
|
| 3 |
Nika Aleksandra Kravos Tramšek, Andrijana Koceva, Mitja Krajnc. Switch from premixed insulin analogue to degludec-liraglutide combination: a CGM study. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1715800
|
| 4 |
Kyriakos Kintzoglanakis, Christos Diamantis, Anargiros Mariolis, Stavroula A Paschou. Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. Diabetes and Vascular Disease Research 2024; 21(4) doi: 10.1177/14791641241269743
|
| 5 |
Stephen Colagiuri, Antonio Ceriello. 4. Blood glucose-lowering therapies – Insulin options for type 2 diabetes. Diabetes Research and Clinical Practice 2025; 222: 112148 doi: 10.1016/j.diabres.2025.112148
|